nodes	percent_of_prediction	percent_of_DWPC	metapath
Trametinib—CYP2C8—Bupropion—obesity	0.109	0.246	CbGbCtD
Trametinib—CYP2C8—Cimetidine—obesity	0.0803	0.18	CbGbCtD
Trametinib—CYP3A4—Sibutramine—obesity	0.0688	0.155	CbGbCtD
Trametinib—CYP3A4—Benzphetamine—obesity	0.0522	0.117	CbGbCtD
Trametinib—CYP3A4—Bupropion—obesity	0.0443	0.0997	CbGbCtD
Trametinib—CYP3A4—Orlistat—obesity	0.0362	0.0813	CbGbCtD
Trametinib—CYP3A4—Cimetidine—obesity	0.0326	0.0732	CbGbCtD
Trametinib—CYP3A4—Topiramate—obesity	0.0213	0.0479	CbGbCtD
Trametinib—MAP2K1—hindbrain—obesity	0.0082	0.128	CbGeAlD
Trametinib—MAP2K1—respiratory system—obesity	0.00501	0.078	CbGeAlD
Trametinib—MAP2K2—islet of Langerhans—obesity	0.00467	0.0727	CbGeAlD
Trametinib—MAP2K2—respiratory system—obesity	0.00441	0.0687	CbGeAlD
Trametinib—MAP2K1—cardiovascular system—obesity	0.00383	0.0597	CbGeAlD
Trametinib—MAP2K1—adipose tissue—obesity	0.00338	0.0527	CbGeAlD
Trametinib—MAP2K2—cardiovascular system—obesity	0.00338	0.0526	CbGeAlD
Trametinib—MAP2K1—digestive system—obesity	0.00318	0.0496	CbGeAlD
Trametinib—MAP2K1—adrenal gland—obesity	0.00303	0.0473	CbGeAlD
Trametinib—MAP2K2—pituitary gland—obesity	0.00299	0.0466	CbGeAlD
Trametinib—MAP2K2—adipose tissue—obesity	0.00298	0.0464	CbGeAlD
Trametinib—MAP2K2—digestive system—obesity	0.0028	0.0437	CbGeAlD
Trametinib—MAP2K2—adrenal gland—obesity	0.00267	0.0416	CbGeAlD
Trametinib—MAP2K1—endocrine gland—obesity	0.00263	0.041	CbGeAlD
Trametinib—MAP2K1—liver—obesity	0.00237	0.0369	CbGeAlD
Trametinib—MAP2K2—endocrine gland—obesity	0.00232	0.0361	CbGeAlD
Trametinib—MAP2K2—liver—obesity	0.00209	0.0325	CbGeAlD
Trametinib—CYP2C8—pituitary gland—obesity	0.00103	0.0161	CbGeAlD
Trametinib—CYP2C8—endocrine gland—obesity	0.000802	0.0125	CbGeAlD
Trametinib—CYP2C8—liver—obesity	0.000723	0.0113	CbGeAlD
Trametinib—CYP3A4—digestive system—obesity	0.000657	0.0102	CbGeAlD
Trametinib—Hyperglycaemia—Sibutramine—obesity	0.000561	0.00256	CcSEcCtD
Trametinib—Urinary tract infection—Orlistat—obesity	0.000557	0.00254	CcSEcCtD
Trametinib—Dizziness—Phenylpropanolamine—obesity	0.000553	0.00252	CcSEcCtD
Trametinib—Phosphatase alkaline increased—Topiramate—obesity	0.000551	0.00251	CcSEcCtD
Trametinib—Diarrhoea—Phentermine—obesity	0.000547	0.00249	CcSEcCtD
Trametinib—Renal failure—Sibutramine—obesity	0.000545	0.00249	CcSEcCtD
Trametinib—CYP3A4—endocrine gland—obesity	0.000543	0.00846	CbGeAlD
Trametinib—Stomatitis—Sibutramine—obesity	0.000541	0.00246	CcSEcCtD
Trametinib—Urinary tract infection—Sibutramine—obesity	0.000539	0.00246	CcSEcCtD
Trametinib—Melaena—Topiramate—obesity	0.000538	0.00245	CcSEcCtD
Trametinib—Pancreatitis—Bupropion—obesity	0.000532	0.00242	CcSEcCtD
Trametinib—Vomiting—Phenylpropanolamine—obesity	0.000532	0.00242	CcSEcCtD
Trametinib—Dizziness—Phentermine—obesity	0.000529	0.00241	CcSEcCtD
Trametinib—Haematuria—Sibutramine—obesity	0.000529	0.00241	CcSEcCtD
Trametinib—Rash—Phenylpropanolamine—obesity	0.000527	0.0024	CcSEcCtD
Trametinib—Dermatitis—Phenylpropanolamine—obesity	0.000527	0.0024	CcSEcCtD
Trametinib—Body temperature increased—Cimetidine—obesity	0.000524	0.00239	CcSEcCtD
Trametinib—Epistaxis—Sibutramine—obesity	0.000523	0.00239	CcSEcCtD
Trametinib—Abdominal discomfort—Bupropion—obesity	0.00052	0.00237	CcSEcCtD
Trametinib—Haemoglobin—Orlistat—obesity	0.000517	0.00236	CcSEcCtD
Trametinib—Haemorrhage—Orlistat—obesity	0.000515	0.00235	CcSEcCtD
Trametinib—Dry eye—Topiramate—obesity	0.000509	0.00232	CcSEcCtD
Trametinib—Vomiting—Phentermine—obesity	0.000509	0.00232	CcSEcCtD
Trametinib—Urinary tract disorder—Orlistat—obesity	0.000508	0.00232	CcSEcCtD
Trametinib—Bradycardia—Sibutramine—obesity	0.000507	0.00231	CcSEcCtD
Trametinib—Oedema peripheral—Orlistat—obesity	0.000507	0.00231	CcSEcCtD
Trametinib—Urethral disorder—Orlistat—obesity	0.000505	0.0023	CcSEcCtD
Trametinib—Rash—Phentermine—obesity	0.000504	0.0023	CcSEcCtD
Trametinib—Dermatitis—Phentermine—obesity	0.000504	0.0023	CcSEcCtD
Trametinib—Headache—Phentermine—obesity	0.000501	0.00228	CcSEcCtD
Trametinib—Rash maculo-papular—Topiramate—obesity	0.000501	0.00228	CcSEcCtD
Trametinib—Haemoglobin—Sibutramine—obesity	0.000501	0.00228	CcSEcCtD
Trametinib—Haemorrhage—Sibutramine—obesity	0.000498	0.00227	CcSEcCtD
Trametinib—Mouth ulceration—Topiramate—obesity	0.000498	0.00227	CcSEcCtD
Trametinib—Neoplasm—Topiramate—obesity	0.000498	0.00227	CcSEcCtD
Trametinib—Nausea—Phenylpropanolamine—obesity	0.000497	0.00226	CcSEcCtD
Trametinib—Oedema peripheral—Sibutramine—obesity	0.000491	0.00224	CcSEcCtD
Trametinib—CYP3A4—liver—obesity	0.00049	0.00763	CbGeAlD
Trametinib—Hyperglycaemia—Bupropion—obesity	0.000489	0.00223	CcSEcCtD
Trametinib—Infestation NOS—Bupropion—obesity	0.000484	0.0022	CcSEcCtD
Trametinib—Infestation—Bupropion—obesity	0.000484	0.0022	CcSEcCtD
Trametinib—Diarrhoea—Diethylpropion—obesity	0.000476	0.00217	CcSEcCtD
Trametinib—Nausea—Phentermine—obesity	0.000475	0.00217	CcSEcCtD
Trametinib—Asthenia—Cimetidine—obesity	0.000475	0.00217	CcSEcCtD
Trametinib—Stomatitis—Bupropion—obesity	0.000471	0.00215	CcSEcCtD
Trametinib—Urinary tract infection—Bupropion—obesity	0.00047	0.00214	CcSEcCtD
Trametinib—Eye disorder—Sibutramine—obesity	0.000465	0.00212	CcSEcCtD
Trametinib—Mediastinal disorder—Orlistat—obesity	0.000464	0.00211	CcSEcCtD
Trametinib—Dizziness—Diethylpropion—obesity	0.00046	0.0021	CcSEcCtD
Trametinib—Blood alkaline phosphatase increased—Topiramate—obesity	0.00046	0.0021	CcSEcCtD
Trametinib—Epistaxis—Bupropion—obesity	0.000456	0.00208	CcSEcCtD
Trametinib—Diarrhoea—Cimetidine—obesity	0.000453	0.00207	CcSEcCtD
Trametinib—Angiopathy—Sibutramine—obesity	0.000452	0.00206	CcSEcCtD
Trametinib—Mental disorder—Orlistat—obesity	0.000451	0.00205	CcSEcCtD
Trametinib—Malnutrition—Orlistat—obesity	0.000448	0.00204	CcSEcCtD
Trametinib—Chills—Sibutramine—obesity	0.000447	0.00204	CcSEcCtD
Trametinib—Arrhythmia—Sibutramine—obesity	0.000445	0.00203	CcSEcCtD
Trametinib—Vomiting—Diethylpropion—obesity	0.000443	0.00202	CcSEcCtD
Trametinib—Rash—Diethylpropion—obesity	0.000439	0.002	CcSEcCtD
Trametinib—Dysgeusia—Orlistat—obesity	0.000439	0.002	CcSEcCtD
Trametinib—Dermatitis—Diethylpropion—obesity	0.000438	0.002	CcSEcCtD
Trametinib—Dizziness—Cimetidine—obesity	0.000438	0.002	CcSEcCtD
Trametinib—Haemoglobin—Bupropion—obesity	0.000436	0.00199	CcSEcCtD
Trametinib—Headache—Diethylpropion—obesity	0.000436	0.00199	CcSEcCtD
Trametinib—Haemorrhage—Bupropion—obesity	0.000434	0.00198	CcSEcCtD
Trametinib—Malnutrition—Sibutramine—obesity	0.000434	0.00198	CcSEcCtD
Trametinib—Back pain—Orlistat—obesity	0.000433	0.00198	CcSEcCtD
Trametinib—Muscle spasms—Orlistat—obesity	0.000431	0.00196	CcSEcCtD
Trametinib—Urinary tract disorder—Bupropion—obesity	0.000429	0.00195	CcSEcCtD
Trametinib—Oedema peripheral—Bupropion—obesity	0.000428	0.00195	CcSEcCtD
Trametinib—Connective tissue disorder—Bupropion—obesity	0.000427	0.00194	CcSEcCtD
Trametinib—Urethral disorder—Bupropion—obesity	0.000426	0.00194	CcSEcCtD
Trametinib—Dysgeusia—Sibutramine—obesity	0.000425	0.00194	CcSEcCtD
Trametinib—Vision blurred—Orlistat—obesity	0.000422	0.00192	CcSEcCtD
Trametinib—Vomiting—Cimetidine—obesity	0.000421	0.00192	CcSEcCtD
Trametinib—Back pain—Sibutramine—obesity	0.000419	0.00191	CcSEcCtD
Trametinib—Rash—Cimetidine—obesity	0.000418	0.0019	CcSEcCtD
Trametinib—Dermatitis—Cimetidine—obesity	0.000417	0.0019	CcSEcCtD
Trametinib—Muscle spasms—Sibutramine—obesity	0.000417	0.0019	CcSEcCtD
Trametinib—Headache—Cimetidine—obesity	0.000415	0.00189	CcSEcCtD
Trametinib—Nausea—Diethylpropion—obesity	0.000413	0.00188	CcSEcCtD
Trametinib—Vision blurred—Sibutramine—obesity	0.000409	0.00186	CcSEcCtD
Trametinib—Eye disorder—Bupropion—obesity	0.000406	0.00185	CcSEcCtD
Trametinib—Cardiac disorder—Bupropion—obesity	0.000403	0.00184	CcSEcCtD
Trametinib—Hyponatraemia—Topiramate—obesity	0.000402	0.00183	CcSEcCtD
Trametinib—Anaemia—Sibutramine—obesity	0.000401	0.00183	CcSEcCtD
Trametinib—Pain in extremity—Topiramate—obesity	0.0004	0.00182	CcSEcCtD
Trametinib—Angiopathy—Bupropion—obesity	0.000394	0.0018	CcSEcCtD
Trametinib—Nausea—Cimetidine—obesity	0.000393	0.00179	CcSEcCtD
Trametinib—Mediastinal disorder—Bupropion—obesity	0.000391	0.00178	CcSEcCtD
Trametinib—Cough—Orlistat—obesity	0.000391	0.00178	CcSEcCtD
Trametinib—Chills—Bupropion—obesity	0.00039	0.00178	CcSEcCtD
Trametinib—Leukopenia—Sibutramine—obesity	0.000388	0.00177	CcSEcCtD
Trametinib—Arrhythmia—Bupropion—obesity	0.000388	0.00177	CcSEcCtD
Trametinib—Myalgia—Orlistat—obesity	0.000381	0.00174	CcSEcCtD
Trametinib—Mental disorder—Bupropion—obesity	0.00038	0.00173	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000379	0.00173	CcSEcCtD
Trametinib—Cough—Sibutramine—obesity	0.000378	0.00172	CcSEcCtD
Trametinib—Malnutrition—Bupropion—obesity	0.000378	0.00172	CcSEcCtD
Trametinib—Blood creatinine increased—Topiramate—obesity	0.000375	0.00171	CcSEcCtD
Trametinib—Hypertension—Sibutramine—obesity	0.000374	0.00171	CcSEcCtD
Trametinib—Dry mouth—Orlistat—obesity	0.000373	0.0017	CcSEcCtD
Trametinib—Dehydration—Topiramate—obesity	0.000372	0.00169	CcSEcCtD
Trametinib—Dysgeusia—Bupropion—obesity	0.00037	0.00169	CcSEcCtD
Trametinib—Arthralgia—Sibutramine—obesity	0.000369	0.00168	CcSEcCtD
Trametinib—Myalgia—Sibutramine—obesity	0.000369	0.00168	CcSEcCtD
Trametinib—Oedema—Orlistat—obesity	0.000366	0.00167	CcSEcCtD
Trametinib—Back pain—Bupropion—obesity	0.000366	0.00167	CcSEcCtD
Trametinib—Abdominal pain upper—Topiramate—obesity	0.000365	0.00166	CcSEcCtD
Trametinib—Hypokalaemia—Topiramate—obesity	0.000364	0.00166	CcSEcCtD
Trametinib—Muscle spasms—Bupropion—obesity	0.000363	0.00166	CcSEcCtD
Trametinib—Infection—Orlistat—obesity	0.000363	0.00166	CcSEcCtD
Trametinib—Dry mouth—Sibutramine—obesity	0.000361	0.00165	CcSEcCtD
Trametinib—Aspartate aminotransferase increased—Topiramate—obesity	0.00036	0.00164	CcSEcCtD
Trametinib—Nervous system disorder—Orlistat—obesity	0.000359	0.00163	CcSEcCtD
Trametinib—Vision blurred—Bupropion—obesity	0.000356	0.00162	CcSEcCtD
Trametinib—Skin disorder—Orlistat—obesity	0.000355	0.00162	CcSEcCtD
Trametinib—Oedema—Sibutramine—obesity	0.000354	0.00161	CcSEcCtD
Trametinib—Hyperhidrosis—Orlistat—obesity	0.000353	0.00161	CcSEcCtD
Trametinib—Alanine aminotransferase increased—Topiramate—obesity	0.000353	0.00161	CcSEcCtD
Trametinib—Infection—Sibutramine—obesity	0.000352	0.0016	CcSEcCtD
Trametinib—Anaemia—Bupropion—obesity	0.000349	0.00159	CcSEcCtD
Trametinib—Thrombocytopenia—Sibutramine—obesity	0.000346	0.00158	CcSEcCtD
Trametinib—Skin disorder—Sibutramine—obesity	0.000344	0.00157	CcSEcCtD
Trametinib—Hyperhidrosis—Sibutramine—obesity	0.000342	0.00156	CcSEcCtD
Trametinib—Pancreatitis—Topiramate—obesity	0.000339	0.00154	CcSEcCtD
Trametinib—Leukopenia—Bupropion—obesity	0.000338	0.00154	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Orlistat—obesity	0.000333	0.00152	CcSEcCtD
Trametinib—Abdominal discomfort—Topiramate—obesity	0.000331	0.00151	CcSEcCtD
Trametinib—Insomnia—Orlistat—obesity	0.000331	0.00151	CcSEcCtD
Trametinib—Cough—Bupropion—obesity	0.00033	0.0015	CcSEcCtD
Trametinib—Hypertension—Bupropion—obesity	0.000326	0.00149	CcSEcCtD
Trametinib—Neutropenia—Topiramate—obesity	0.000323	0.00147	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Sibutramine—obesity	0.000322	0.00147	CcSEcCtD
Trametinib—Arthralgia—Bupropion—obesity	0.000322	0.00147	CcSEcCtD
Trametinib—Myalgia—Bupropion—obesity	0.000322	0.00147	CcSEcCtD
Trametinib—Insomnia—Sibutramine—obesity	0.00032	0.00146	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.00032	0.00146	CcSEcCtD
Trametinib—Decreased appetite—Orlistat—obesity	0.000318	0.00145	CcSEcCtD
Trametinib—Gastrointestinal disorder—Orlistat—obesity	0.000316	0.00144	CcSEcCtD
Trametinib—Fatigue—Orlistat—obesity	0.000315	0.00144	CcSEcCtD
Trametinib—Dry mouth—Bupropion—obesity	0.000315	0.00143	CcSEcCtD
Trametinib—Hyperglycaemia—Topiramate—obesity	0.000312	0.00142	CcSEcCtD
Trametinib—Oedema—Bupropion—obesity	0.000308	0.00141	CcSEcCtD
Trametinib—Infestation NOS—Topiramate—obesity	0.000308	0.0014	CcSEcCtD
Trametinib—Infestation—Topiramate—obesity	0.000308	0.0014	CcSEcCtD
Trametinib—Decreased appetite—Sibutramine—obesity	0.000308	0.0014	CcSEcCtD
Trametinib—Infection—Bupropion—obesity	0.000306	0.0014	CcSEcCtD
Trametinib—Gastrointestinal disorder—Sibutramine—obesity	0.000306	0.00139	CcSEcCtD
Trametinib—Renal failure—Topiramate—obesity	0.000303	0.00138	CcSEcCtD
Trametinib—Constipation—Sibutramine—obesity	0.000303	0.00138	CcSEcCtD
Trametinib—Nervous system disorder—Bupropion—obesity	0.000303	0.00138	CcSEcCtD
Trametinib—Thrombocytopenia—Bupropion—obesity	0.000302	0.00138	CcSEcCtD
Trametinib—Stomatitis—Topiramate—obesity	0.0003	0.00137	CcSEcCtD
Trametinib—Skin disorder—Bupropion—obesity	0.0003	0.00137	CcSEcCtD
Trametinib—Urinary tract infection—Topiramate—obesity	0.0003	0.00137	CcSEcCtD
Trametinib—Gastrointestinal pain—Orlistat—obesity	0.000299	0.00136	CcSEcCtD
Trametinib—Hyperhidrosis—Bupropion—obesity	0.000298	0.00136	CcSEcCtD
Trametinib—Haematuria—Topiramate—obesity	0.000294	0.00134	CcSEcCtD
Trametinib—Epistaxis—Topiramate—obesity	0.000291	0.00132	CcSEcCtD
Trametinib—Gastrointestinal pain—Sibutramine—obesity	0.000289	0.00132	CcSEcCtD
Trametinib—Body temperature increased—Orlistat—obesity	0.000289	0.00132	CcSEcCtD
Trametinib—Abdominal pain—Orlistat—obesity	0.000289	0.00132	CcSEcCtD
Trametinib—Bradycardia—Topiramate—obesity	0.000282	0.00128	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Bupropion—obesity	0.000281	0.00128	CcSEcCtD
Trametinib—Body temperature increased—Sibutramine—obesity	0.00028	0.00127	CcSEcCtD
Trametinib—Abdominal pain—Sibutramine—obesity	0.00028	0.00127	CcSEcCtD
Trametinib—Insomnia—Bupropion—obesity	0.000279	0.00127	CcSEcCtD
Trametinib—Haemoglobin—Topiramate—obesity	0.000278	0.00127	CcSEcCtD
Trametinib—Haemorrhage—Topiramate—obesity	0.000277	0.00126	CcSEcCtD
Trametinib—Urinary tract disorder—Topiramate—obesity	0.000273	0.00125	CcSEcCtD
Trametinib—Oedema peripheral—Topiramate—obesity	0.000273	0.00124	CcSEcCtD
Trametinib—Connective tissue disorder—Topiramate—obesity	0.000272	0.00124	CcSEcCtD
Trametinib—Urethral disorder—Topiramate—obesity	0.000271	0.00124	CcSEcCtD
Trametinib—Decreased appetite—Bupropion—obesity	0.000268	0.00122	CcSEcCtD
Trametinib—Gastrointestinal disorder—Bupropion—obesity	0.000266	0.00121	CcSEcCtD
Trametinib—Fatigue—Bupropion—obesity	0.000266	0.00121	CcSEcCtD
Trametinib—Constipation—Bupropion—obesity	0.000264	0.0012	CcSEcCtD
Trametinib—Asthenia—Orlistat—obesity	0.000262	0.0012	CcSEcCtD
Trametinib—Pruritus—Orlistat—obesity	0.000259	0.00118	CcSEcCtD
Trametinib—Eye disorder—Topiramate—obesity	0.000259	0.00118	CcSEcCtD
Trametinib—Cardiac disorder—Topiramate—obesity	0.000257	0.00117	CcSEcCtD
Trametinib—Asthenia—Sibutramine—obesity	0.000254	0.00116	CcSEcCtD
Trametinib—Gastrointestinal pain—Bupropion—obesity	0.000252	0.00115	CcSEcCtD
Trametinib—Angiopathy—Topiramate—obesity	0.000251	0.00114	CcSEcCtD
Trametinib—Pruritus—Sibutramine—obesity	0.00025	0.00114	CcSEcCtD
Trametinib—Diarrhoea—Orlistat—obesity	0.00025	0.00114	CcSEcCtD
Trametinib—Mediastinal disorder—Topiramate—obesity	0.000249	0.00114	CcSEcCtD
Trametinib—Chills—Topiramate—obesity	0.000248	0.00113	CcSEcCtD
Trametinib—Abdominal pain—Bupropion—obesity	0.000244	0.00111	CcSEcCtD
Trametinib—Body temperature increased—Bupropion—obesity	0.000244	0.00111	CcSEcCtD
Trametinib—Mental disorder—Topiramate—obesity	0.000242	0.0011	CcSEcCtD
Trametinib—Diarrhoea—Sibutramine—obesity	0.000242	0.0011	CcSEcCtD
Trametinib—Dizziness—Orlistat—obesity	0.000242	0.0011	CcSEcCtD
Trametinib—Malnutrition—Topiramate—obesity	0.000241	0.0011	CcSEcCtD
Trametinib—Erythema—Topiramate—obesity	0.000241	0.0011	CcSEcCtD
Trametinib—Dysgeusia—Topiramate—obesity	0.000236	0.00107	CcSEcCtD
Trametinib—Dizziness—Sibutramine—obesity	0.000234	0.00107	CcSEcCtD
Trametinib—Back pain—Topiramate—obesity	0.000233	0.00106	CcSEcCtD
Trametinib—Vomiting—Orlistat—obesity	0.000232	0.00106	CcSEcCtD
Trametinib—Muscle spasms—Topiramate—obesity	0.000232	0.00106	CcSEcCtD
Trametinib—Rash—Orlistat—obesity	0.000231	0.00105	CcSEcCtD
Trametinib—Dermatitis—Orlistat—obesity	0.00023	0.00105	CcSEcCtD
Trametinib—Headache—Orlistat—obesity	0.000229	0.00104	CcSEcCtD
Trametinib—Vision blurred—Topiramate—obesity	0.000227	0.00103	CcSEcCtD
Trametinib—Vomiting—Sibutramine—obesity	0.000225	0.00103	CcSEcCtD
Trametinib—Rash—Sibutramine—obesity	0.000223	0.00102	CcSEcCtD
Trametinib—Dermatitis—Sibutramine—obesity	0.000223	0.00102	CcSEcCtD
Trametinib—Anaemia—Topiramate—obesity	0.000223	0.00101	CcSEcCtD
Trametinib—Headache—Sibutramine—obesity	0.000222	0.00101	CcSEcCtD
Trametinib—Asthenia—Bupropion—obesity	0.000221	0.00101	CcSEcCtD
Trametinib—Pruritus—Bupropion—obesity	0.000218	0.000995	CcSEcCtD
Trametinib—Nausea—Orlistat—obesity	0.000217	0.00099	CcSEcCtD
Trametinib—Leukopenia—Topiramate—obesity	0.000216	0.000982	CcSEcCtD
Trametinib—Diarrhoea—Bupropion—obesity	0.000211	0.000962	CcSEcCtD
Trametinib—Nausea—Sibutramine—obesity	0.00021	0.000958	CcSEcCtD
Trametinib—Cough—Topiramate—obesity	0.00021	0.000958	CcSEcCtD
Trametinib—Hypertension—Topiramate—obesity	0.000208	0.000948	CcSEcCtD
Trametinib—Arthralgia—Topiramate—obesity	0.000205	0.000934	CcSEcCtD
Trametinib—Myalgia—Topiramate—obesity	0.000205	0.000934	CcSEcCtD
Trametinib—Dizziness—Bupropion—obesity	0.000204	0.00093	CcSEcCtD
Trametinib—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000204	0.000928	CcSEcCtD
Trametinib—Dry mouth—Topiramate—obesity	0.000201	0.000914	CcSEcCtD
Trametinib—Oedema—Topiramate—obesity	0.000197	0.000896	CcSEcCtD
Trametinib—Vomiting—Bupropion—obesity	0.000196	0.000894	CcSEcCtD
Trametinib—Infection—Topiramate—obesity	0.000195	0.00089	CcSEcCtD
Trametinib—Rash—Bupropion—obesity	0.000195	0.000886	CcSEcCtD
Trametinib—Dermatitis—Bupropion—obesity	0.000194	0.000886	CcSEcCtD
Trametinib—Headache—Bupropion—obesity	0.000193	0.000881	CcSEcCtD
Trametinib—Nervous system disorder—Topiramate—obesity	0.000193	0.000878	CcSEcCtD
Trametinib—Thrombocytopenia—Topiramate—obesity	0.000192	0.000877	CcSEcCtD
Trametinib—Skin disorder—Topiramate—obesity	0.000191	0.00087	CcSEcCtD
Trametinib—Hyperhidrosis—Topiramate—obesity	0.00019	0.000866	CcSEcCtD
Trametinib—Nausea—Bupropion—obesity	0.000183	0.000835	CcSEcCtD
Trametinib—Musculoskeletal discomfort—Topiramate—obesity	0.000179	0.000816	CcSEcCtD
Trametinib—Insomnia—Topiramate—obesity	0.000178	0.00081	CcSEcCtD
Trametinib—Decreased appetite—Topiramate—obesity	0.000171	0.000779	CcSEcCtD
Trametinib—Gastrointestinal disorder—Topiramate—obesity	0.00017	0.000773	CcSEcCtD
Trametinib—Fatigue—Topiramate—obesity	0.000169	0.000772	CcSEcCtD
Trametinib—Constipation—Topiramate—obesity	0.000168	0.000766	CcSEcCtD
Trametinib—Gastrointestinal pain—Topiramate—obesity	0.000161	0.000732	CcSEcCtD
Trametinib—Abdominal pain—Topiramate—obesity	0.000155	0.000708	CcSEcCtD
Trametinib—Body temperature increased—Topiramate—obesity	0.000155	0.000708	CcSEcCtD
Trametinib—Asthenia—Topiramate—obesity	0.000141	0.000643	CcSEcCtD
Trametinib—Pruritus—Topiramate—obesity	0.000139	0.000634	CcSEcCtD
Trametinib—Diarrhoea—Topiramate—obesity	0.000134	0.000613	CcSEcCtD
Trametinib—Dizziness—Topiramate—obesity	0.00013	0.000592	CcSEcCtD
Trametinib—Vomiting—Topiramate—obesity	0.000125	0.00057	CcSEcCtD
Trametinib—Rash—Topiramate—obesity	0.000124	0.000565	CcSEcCtD
Trametinib—Dermatitis—Topiramate—obesity	0.000124	0.000564	CcSEcCtD
Trametinib—Headache—Topiramate—obesity	0.000123	0.000561	CcSEcCtD
Trametinib—Nausea—Topiramate—obesity	0.000117	0.000532	CcSEcCtD
Trametinib—CYP2C8—Metabolism—AKR1C3—obesity	9.76e-06	3.59e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PNLIP—obesity	9.72e-06	3.58e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SRD5A1—obesity	9.72e-06	3.58e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCD—obesity	9.71e-06	3.58e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS2—obesity	9.65e-06	3.56e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AGT—obesity	9.64e-06	3.55e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TYK2—obesity	9.63e-06	3.55e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SCARB1—obesity	9.61e-06	3.54e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—RHOA—obesity	9.55e-06	3.52e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—HTR2A—obesity	9.51e-06	3.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—C3—obesity	9.49e-06	3.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SDC3—obesity	9.48e-06	3.49e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—obesity	9.47e-06	3.49e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PIK3R1—obesity	9.45e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—NOS3—obesity	9.45e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MTOR—obesity	9.45e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PIK3CB—obesity	9.45e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—LEP—obesity	9.45e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOE—obesity	9.45e-06	3.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—IL6—obesity	9.36e-06	3.45e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CAV1—obesity	9.36e-06	3.45e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—ALB—obesity	9.35e-06	3.45e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—APOA1—obesity	9.34e-06	3.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MTOR—obesity	9.33e-06	3.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PIK3CB—obesity	9.33e-06	3.44e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SREBF1—obesity	9.33e-06	3.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL1B—obesity	9.31e-06	3.43e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP26B1—obesity	9.27e-06	3.41e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HK2—obesity	9.27e-06	3.41e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—STS—obesity	9.27e-06	3.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PTGS2—obesity	9.24e-06	3.4e-05	CbGpPWpGaD
Trametinib—MAP2K1—Developmental Biology—AKT1—obesity	9.15e-06	3.37e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT2—obesity	9.07e-06	3.34e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARD—obesity	9.07e-06	3.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS2—obesity	9.03e-06	3.33e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AGT—obesity	9.02e-06	3.32e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—ESR1—obesity	9.02e-06	3.32e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—obesity	8.95e-06	3.3e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—F2—obesity	8.91e-06	3.28e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PRKCB—obesity	8.91e-06	3.28e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC27A1—obesity	8.89e-06	3.27e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—FASN—obesity	8.88e-06	3.27e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—BCHE—obesity	8.84e-06	3.26e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOE—obesity	8.84e-06	3.26e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—LEP—obesity	8.84e-06	3.26e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—BAD—obesity	8.8e-06	3.24e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—IL6—obesity	8.76e-06	3.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CAV1—obesity	8.76e-06	3.23e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—APOA1—obesity	8.74e-06	3.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PIK3CB—obesity	8.73e-06	3.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MTOR—obesity	8.73e-06	3.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GLUL—obesity	8.72e-06	3.21e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FABP4—obesity	8.72e-06	3.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL1B—obesity	8.71e-06	3.21e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PTGS2—obesity	8.65e-06	3.19e-05	CbGpPWpGaD
Trametinib—MAP2K2—Innate Immune System—AKT1—obesity	8.64e-06	3.18e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—MAPK8—obesity	8.54e-06	3.15e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP2E1—obesity	8.53e-06	3.14e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CG—obesity	8.52e-06	3.14e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—ESR1—obesity	8.44e-06	3.11e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NQO1—obesity	8.43e-06	3.11e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IRS1—obesity	8.43e-06	3.1e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—F2—obesity	8.33e-06	3.07e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PRKCB—obesity	8.33e-06	3.07e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HSD11B1—obesity	8.26e-06	3.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UCP3—obesity	8.26e-06	3.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—UCP2—obesity	8.26e-06	3.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ECHS1—obesity	8.26e-06	3.04e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—obesity	8.26e-06	3.04e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—BAD—obesity	8.23e-06	3.03e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—obesity	8.18e-06	3.01e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ADH1B—obesity	8.13e-06	2.99e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—POMC—obesity	8.11e-06	2.99e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GCG—obesity	8.09e-06	2.98e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—SLC2A4—obesity	8.09e-06	2.98e-05	CbGpPWpGaD
Trametinib—MAP2K1—Innate Immune System—AKT1—obesity	8.08e-06	2.98e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—INS—obesity	8.07e-06	2.97e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPAM—obesity	8e-06	2.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARGC1B—obesity	8e-06	2.95e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ACSL1—obesity	8e-06	2.95e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—MAPK8—obesity	7.99e-06	2.94e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYCS—obesity	7.98e-06	2.94e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CG—obesity	7.98e-06	2.94e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—CCL2—obesity	7.94e-06	2.92e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IRS1—obesity	7.88e-06	2.9e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GGT1—obesity	7.83e-06	2.88e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GOT1—obesity	7.83e-06	2.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—STAT3—obesity	7.81e-06	2.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IGF1—obesity	7.81e-06	2.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT2—obesity	7.8e-06	2.87e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HADH—obesity	7.77e-06	2.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FADS1—obesity	7.77e-06	2.86e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PCK1—obesity	7.77e-06	2.86e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NCOA1—obesity	7.71e-06	2.84e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—STK11—obesity	7.6e-06	2.8e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CYP19A1—obesity	7.6e-06	2.8e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—POMC—obesity	7.59e-06	2.8e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ACP5—obesity	7.56e-06	2.78e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—INS—obesity	7.55e-06	2.78e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CD—obesity	7.49e-06	2.76e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—CCL2—obesity	7.43e-06	2.74e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—SERPINE1—obesity	7.41e-06	2.73e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—G6PD—obesity	7.36e-06	2.71e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—STAT3—obesity	7.3e-06	2.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IGF1—obesity	7.3e-06	2.69e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT2—obesity	7.3e-06	2.69e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SREBF2—obesity	7.27e-06	2.68e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HK1—obesity	7.27e-06	2.68e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TYK2—obesity	7.21e-06	2.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—STAT3—obesity	7.21e-06	2.66e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—RHOA—obesity	7.15e-06	2.63e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—NOS3—obesity	7.08e-06	2.61e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3R1—obesity	7.08e-06	2.61e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—COMT—obesity	7.07e-06	2.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPA—obesity	7.02e-06	2.59e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CD—obesity	7.01e-06	2.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARGC1A—obesity	6.97e-06	2.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GNB3—obesity	6.97e-06	2.57e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—HMOX1—obesity	6.94e-06	2.56e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—SERPINE1—obesity	6.93e-06	2.55e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPIN1—obesity	6.87e-06	2.53e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GNAS—obesity	6.79e-06	2.5e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TYK2—obesity	6.74e-06	2.48e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—STAT3—obesity	6.74e-06	2.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—PIK3CA—obesity	6.74e-06	2.48e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA5—obesity	6.74e-06	2.48e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—MYC—obesity	6.7e-06	2.47e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—RHOA—obesity	6.69e-06	2.46e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—TGFB1—obesity	6.68e-06	2.46e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOB—obesity	6.64e-06	2.45e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—NOS3—obesity	6.62e-06	2.44e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3R1—obesity	6.62e-06	2.44e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MTOR—obesity	6.53e-06	2.41e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CB—obesity	6.53e-06	2.41e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC22A1—obesity	6.43e-06	2.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CLOCK—obesity	6.43e-06	2.37e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—LPL—obesity	6.34e-06	2.34e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—PIK3CA—obesity	6.31e-06	2.32e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—MYC—obesity	6.27e-06	2.31e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SULT2A1—obesity	6.26e-06	2.31e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GLP1R—obesity	6.26e-06	2.31e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—TGFB1—obesity	6.25e-06	2.3e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—GPX1—obesity	6.19e-06	2.28e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DPYD—obesity	6.16e-06	2.27e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—PIK3CA—obesity	6.16e-06	2.27e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MTOR—obesity	6.11e-06	2.25e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CB—obesity	6.11e-06	2.25e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CD36—obesity	6.03e-06	2.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—IL6—obesity	5.97e-06	2.2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PRKAR2B—obesity	5.93e-06	2.18e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—DCN—obesity	5.89e-06	2.17e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—PIK3CA—obesity	5.76e-06	2.12e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CPT1A—obesity	5.73e-06	2.11e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—MTHFR—obesity	5.71e-06	2.1e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—PIK3CA—obesity	5.69e-06	2.09e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MMP9—obesity	5.68e-06	2.09e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NAMPT—obesity	5.62e-06	2.07e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARA—obesity	5.6e-06	2.06e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—IL6—obesity	5.58e-06	2.06e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LIPC—obesity	5.58e-06	2.06e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCK—obesity	5.58e-06	2.06e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOC3—obesity	5.55e-06	2.04e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MAPK8—obesity	5.52e-06	2.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling by GPCR—AKT1—obesity	5.51e-06	2.03e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—IL6—obesity	5.45e-06	2.01e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AGT—obesity	5.43e-06	2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CETP—obesity	5.38e-06	1.98e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SDC1—obesity	5.32e-06	1.96e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—PIK3CA—obesity	5.32e-06	1.96e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOE—obesity	5.32e-06	1.96e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MMP9—obesity	5.31e-06	1.96e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—CAV1—obesity	5.27e-06	1.94e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—APOA1—obesity	5.26e-06	1.94e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKR1C3—obesity	5.24e-06	1.93e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MAPK8—obesity	5.17e-06	1.9e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SCARB1—obesity	5.16e-06	1.9e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling by GPCR—AKT1—obesity	5.15e-06	1.9e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—IL6—obesity	5.1e-06	1.88e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—STAT3—obesity	5.05e-06	1.86e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—IL6—obesity	5.04e-06	1.85e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	5.03e-06	1.85e-05	CbGpPWpGaD
Trametinib—MAP2K2—Immune System—AKT1—obesity	5.03e-06	1.85e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SREBF1—obesity	5.01e-06	1.84e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT2—obesity	4.87e-06	1.79e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CG—obesity	4.8e-06	1.77e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—FASN—obesity	4.77e-06	1.76e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—BCHE—obesity	4.75e-06	1.75e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—STAT3—obesity	4.72e-06	1.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—IL6—obesity	4.71e-06	1.74e-05	CbGpPWpGaD
Trametinib—MAP2K1—Immune System—AKT1—obesity	4.71e-06	1.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—MYC—obesity	4.69e-06	1.73e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—TGFB1—obesity	4.68e-06	1.72e-05	CbGpPWpGaD
Trametinib—MAP2K2—Disease—AKT1—obesity	4.65e-06	1.71e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PPARG—obesity	4.63e-06	1.71e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP2E1—obesity	4.58e-06	1.69e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—POMC—obesity	4.57e-06	1.68e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—INS—obesity	4.54e-06	1.67e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NQO1—obesity	4.53e-06	1.67e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—MYC—obesity	4.39e-06	1.62e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—TGFB1—obesity	4.38e-06	1.61e-05	CbGpPWpGaD
Trametinib—MAP2K1—Disease—AKT1—obesity	4.35e-06	1.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—SLC2A4—obesity	4.34e-06	1.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GCG—obesity	4.34e-06	1.6e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYCS—obesity	4.28e-06	1.58e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CD—obesity	4.22e-06	1.55e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GOT1—obesity	4.2e-06	1.55e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GGT1—obesity	4.2e-06	1.55e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—ALB—obesity	4.17e-06	1.53e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NCOA1—obesity	4.14e-06	1.53e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—STK11—obesity	4.08e-06	1.5e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CYP19A1—obesity	4.08e-06	1.5e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—NOS3—obesity	3.98e-06	1.47e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3R1—obesity	3.98e-06	1.47e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—PIK3CA—obesity	3.98e-06	1.47e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—COMT—obesity	3.79e-06	1.4e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GNB3—obesity	3.74e-06	1.38e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARGC1A—obesity	3.74e-06	1.38e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—PIK3CA—obesity	3.73e-06	1.37e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—HMOX1—obesity	3.72e-06	1.37e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CB—obesity	3.68e-06	1.35e-05	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PTGS2—obesity	3.64e-06	1.34e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GNAS—obesity	3.64e-06	1.34e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOB—obesity	3.57e-06	1.31e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—IL6—obesity	3.53e-06	1.3e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—LPL—obesity	3.41e-06	1.25e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—GPX1—obesity	3.32e-06	1.22e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—IL6—obesity	3.3e-06	1.22e-05	CbGpPWpGaD
Trametinib—MAP2K2—Signaling Pathways—AKT1—obesity	3.25e-06	1.2e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CD36—obesity	3.24e-06	1.19e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—MTHFR—obesity	3.07e-06	1.13e-05	CbGpPWpGaD
Trametinib—MAP2K1—Signaling Pathways—AKT1—obesity	3.04e-06	1.12e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARA—obesity	3.01e-06	1.11e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AGT—obesity	2.91e-06	1.07e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOE—obesity	2.85e-06	1.05e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—CAV1—obesity	2.83e-06	1.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—APOA1—obesity	2.82e-06	1.04e-05	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CG—obesity	2.58e-06	9.49e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PPARG—obesity	2.49e-06	9.16e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—POMC—obesity	2.45e-06	9.03e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—INS—obesity	2.44e-06	8.98e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CD—obesity	2.26e-06	8.34e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—PIK3CA—obesity	2.24e-06	8.26e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—ALB—obesity	2.24e-06	8.24e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3R1—obesity	2.14e-06	7.88e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—NOS3—obesity	2.14e-06	7.88e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CB—obesity	1.97e-06	7.27e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PTGS2—obesity	1.96e-06	7.21e-06	CbGpPWpGaD
Trametinib—CYP2C8—Metabolism—AKT1—obesity	1.83e-06	6.75e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—PIK3CA—obesity	1.2e-06	4.43e-06	CbGpPWpGaD
Trametinib—CYP3A4—Metabolism—AKT1—obesity	9.83e-07	3.62e-06	CbGpPWpGaD
